Evofem Biosciences, Inc. (NASDAQ:EVFM – Get Free Report)’s stock price crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $0.01 and traded as high as $0.01. Evofem Biosciences shares last traded at $0.01, with a volume of 328,147 shares traded.
Evofem Biosciences Trading Down 6.9%
The stock’s 50-day simple moving average is $0.01 and its 200-day simple moving average is $0.01. The stock has a market cap of $1.19 million, a price-to-earnings ratio of -0.02 and a beta of -1.13.
Evofem Biosciences Company Profile
Evofem Biosciences, Inc, a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis.
Further Reading
- Five stocks we like better than Evofem Biosciences
- The Basics of Support and Resistance
- Rayonier-PotlatchDeltic Merger Signals Industry Upside
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Hims & Hers Short Interest Nears All-Time High, Buy The Dip?
- How to Most Effectively Use the MarketBeat Earnings Screener
- This Defense Stock Has a $57B Backlog and New AI Tailwinds
Receive News & Ratings for Evofem Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evofem Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
